Nurix Therapeutics, Inc. (NRIX) reports
- Hansen Gwenn filed Form 4 on 2026-10-15.
- 1,452 shares acquired at $1.86.
- 1,452 shares disposed of at $25.
Gwenn Hansen, reporting
NRIX
Nurix Therapeutics, Inc. SEC filings
Every EDGAR filing for Nurix Therapeutics, Inc. (NRIX), newest first, with AI summaries and stories.
- Ticker
- NRIX
- CIK
- 1549595
- Sector
- Biotech and pharma
- Latest filing
- 3d
Next: earnings expected ~Feb 3 · 10-K expected ~Feb 3 (deadline Jan 29)
Insider activity
No open-market insider buys in the last 30 days.
Also: 3 open-market sales ($699K), 3 grants or exercises.
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4Nurix Therapeutics, Inc.NRIXLIVE ROUTINE144Nurix Therapeutics, Inc.NRIXLIVE Nurix Therapeutics, Inc. files Form 144
- Filer CIK: 0001226675
- Seller: Julia Gregory, Director
- Shares to sell: 22,583
Julia P Gregory, reporting
ROUTINE4Nurix Therapeutics, Inc.NRIXLIVE Nurix Therapeutics, Inc. reports stock transactions
- Gregory Julia P sold 22,583 shares at $23.40
- Gregory Julia P bought 22,583 shares at $1.86
- Stock option vested fully on August 12, 2023
Julia P Gregory, reporting
NOTABLE10-QNurix Therapeutics, Inc.NRIXLIVE Nurix Therapeutics reports Q3 2026 results
- Revenue of $673.1M for Q3 2026
- Net income of $549.8M for Q3 2026
- Cash and cash equivalents of $720.2M as of August 31, 2026
ROUTINE8-KNurix Therapeutics, Inc.NRIXLIVE Nurix Therapeutics reports Q3 2026 results
- Earned $27M from Gilead, Pfizer, and Sanofi collaborations
- Advanced bexobrutideg into Phase 3 trial for CLL
- Received $700M upfront from Roche collaboration
ROUTINE4Nurix Therapeutics, Inc.NRIXLIVE Nurix Therapeutics reports insider trading
- Christine Ring sold 5,786 shares at $23.19
- Christine Ring bought 5,786 shares at $8.72
- Stock option vests through 2027
Christine Ring
ROUTINE144Nurix Therapeutics, Inc.NRIXLIVE Nurix Therapeutics files Form 144
- Filer CIK: 0001817199
- Seller: Christine Ring
- Shares to be sold: 5786
Christine Ring
ROUTINESCHEDULE 13GNurix Therapeutics, Inc.NRIXLIVE Ownership stake disclosure by PERCEPTIVE ADVISORS LLC
PERCEPTIVE ADVISORS LLC, filed by
ROUTINE4Nurix Therapeutics, Inc.NRIXLIVE Christine Ring, insider filing for NRIX
Christine Ring, reporting
ROUTINE144Nurix Therapeutics, Inc.NRIXLIVE Christine Ring, planned sale of NRIX shares
Christine Ring, reporting
ROUTINE4Nurix Therapeutics, Inc.NRIXLIVE Gwenn Hansen, insider filing for NRIX
Gwenn Hansen, reporting
ROUTINESCHEDULE 13G/ANurix Therapeutics, Inc.NRIXLIVE 3 13G filings
Ownership stake disclosure by Redmile Group, LLC (amended)
Show all 3
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13GOwnership stake disclosure
Redmile Group, LLC, filed by
ROUTINESCHEDULE 13GNurix Therapeutics, Inc.NRIXLIVE Ownership stake disclosure by PRICE T ROWE ASSOCIATES INC /MD/
PRICE T ROWE ASSOCIATES INC /MD/, filed by
ROUTINESCHEDULE 13G/ANurix Therapeutics, Inc.NRIXLIVE Ownership stake disclosure by Deep Track Capital, LP (amended)
Deep Track Capital, LP, filed by
ROUTINE4Nurix Therapeutics, Inc.NRIXLIVE Gwenn Hansen, insider filing for NRIX
Gwenn Hansen, reporting
ROUTINE144Nurix Therapeutics, Inc.NRIXLIVE Gwenn Hansen, planned sale of NRIX shares
Gwenn Hansen, reporting
ROUTINE4Nurix Therapeutics, Inc.NRIXLIVE Gwenn Hansen, insider filing for NRIX
Gwenn Hansen, reporting
ROUTINE4Nurix Therapeutics, Inc.NRIXLIVE Houte Hans van, insider filing for NRIX
Houte Hans van, reporting
ROUTINE144Nurix Therapeutics, Inc.NRIXLIVE 2 Form 144 notices
Houte Hans van, planned sale of NRIX shares
Show all 2
- 144Planned insider sale of NRIX shares
- 144Planned insider sale of NRIX shares
Houte Hans van, reporting
ROUTINE4Nurix Therapeutics, Inc.NRIXLIVE Christine Ring, insider filing for NRIX
Christine Ring, reporting
ROUTINE144Nurix Therapeutics, Inc.NRIXLIVE Christine Ring, planned sale of NRIX shares
Christine Ring, reporting
ROUTINESCHEDULE 13GNurix Therapeutics, Inc.NRIXLIVE Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
ROUTINE4Nurix Therapeutics, Inc.NRIXLIVE 3 insider filings
Houte Hans van, insider filing for NRIX
Show all 3
- 4Insider filing for NRIX
- 4Insider filing for NRIX
- 4Insider filing for NRIX
Houte Hans van, reporting
NOTABLE10-QNurix Therapeutics, Inc.NRIXLIVE ROUTINE8-KNurix Therapeutics, Inc.NRIXLIVE ROUTINE4Nurix Therapeutics, Inc.NRIXLIVE Christine Ring, insider filing for NRIX
Christine Ring, reporting
ROUTINE144Nurix Therapeutics, Inc.NRIXLIVE Christine Ring, planned sale of NRIX shares
Christine Ring, reporting
ROUTINE4Nurix Therapeutics, Inc.NRIXLIVE 2 insider filings
Gwenn Hansen, insider filing for NRIX
Show all 2
- 4Insider filing for NRIX
- 4Insider filing for NRIX
Gwenn Hansen, reporting
ROUTINE144Nurix Therapeutics, Inc.NRIXLIVE 2 Form 144 notices
Gwenn Hansen, planned sale of NRIX shares
Show all 2
- 144Planned insider sale of NRIX shares
- 144Planned insider sale of NRIX shares
Gwenn Hansen, reporting
ROUTINE8-KNurix Therapeutics, Inc.NRIXLIVE ROUTINE8-KNurix Therapeutics, Inc.NRIXLIVE ROUTINE4Nurix Therapeutics, Inc.NRIXLIVE Christine Ring, insider filing for NRIX
Christine Ring, reporting
ROUTINE144Nurix Therapeutics, Inc.NRIXLIVE Christine Ring, planned sale of NRIX shares
Christine Ring, reporting
ROUTINE4Nurix Therapeutics, Inc.NRIXLIVE 8 insider filings
Paul M Silva, insider filing for NRIX
Show all 8
- 4Insider filing for NRIX
- 4Insider filing for NRIX
- 4Insider filing for NRIX
- 4Insider filing for NRIX
- 4Insider filing for NRIX
- 4Insider filing for NRIX
- 4Insider filing for NRIX
- 4Insider filing for NRIX
Paul M Silva, reporting
ROUTINESCHEDULE 13GNurix Therapeutics, Inc.NRIXLIVE Ownership stake disclosure by Vestal Point Capital, LP
Vestal Point Capital, LP, filed by
ROUTINE8-KNurix Therapeutics, Inc.NRIXLIVE